Skip to main content
OpenTrials

Clinical trial condition

Ovarian Carcinosarcoma

Explore clinical trials studying Ovarian Carcinosarcoma. Study availability and eligibility vary by location and protocol.

14 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Carcinosarcoma trial results

Recruiting

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

NCT05902988

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +34 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 14 locations
View Trial Details
Recruiting

EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma

NCT05619913

Conditions
Ovarian Carcinosarcoma, Uterine Carcinosarcoma
Locations
  • Prince of Wales Hospital Randwick, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Herston, Queensland, Australia
  • Monash Health Clayton, Victoria, Australia
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View Trial Details
Completed

Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

NCT03648489

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
  • KEM Kliniken Essen-Mitte Essen, Germany
  • Furness General Hospital Barrow in Furness, Cumbria, United Kingdom
View all 15 locations
View Trial Details
Completed

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

NCT02020707

Conditions
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma, +45 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Completed

Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00989651

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +59 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 23 locations
View Trial Details
Completed

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)

NCT00085358

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +35 more
Locations
  • University of California Medical Center At Irvine-Orange Campus Orange, California, United States
  • Colorado Gynecologic Oncology Group Aurora, Colorado, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 16 locations
View Trial Details
Completed

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

NCT01010126

Conditions
Adenocarcinoma, Adnexal Diseases, Adult Hepatocellular Carcinoma, +76 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
View all 61 locations
View Trial Details
Completed

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

NCT01080521

Conditions
Adnexal Diseases, Brenner Tumor, Cognitive Side Effects of Cancer Therapy, +79 more
Locations
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Roy and Patricia Disney Family Cancer Center Burbank, California, United States
View all 182 locations
View Trial Details

Related conditions